Zobrazeno 1 - 10
of 24
pro vyhledávání: '"A G, Gofman"'
Publikováno v:
Ferrous Metallurgy. Bulletin of Scientific , Technical and Economic Information. 76:242-250
Publikováno v:
Psychiatry. 79:95-99
Publikováno v:
IOP Conference Series: Materials Science and Engineering. 597:012012
Autor:
P A Ponizovskiy, A G Gofman
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 115(7)
In this review, authors considered characteristics of depression and alcohol addiction. Depressive disorders comorbid to alcoholism are heterogeneous in their nature and structure and can be observed during alcohol withdrawal syndrome and in remissio
Publikováno v:
Bulletin of Experimental Biology and Medicine. :163-166
The efficiency of potentiated preparations from ethanol and morphine hydrochloride in the therapy of patients with alcohol and opium withdrawal syndromes was compared in an open clinical trial. Potentiated ethanol relieved the major clinical manifest
Publikováno v:
Bulletin of Experimental Biology and Medicine. :167-170
The efficiency of Proproten-100 containing antibodies to S100 protein in ultralow doses and used to relieve somatovegetative and psychoneurological manifestations of the alcohol withdrawal syndrome was studied in a double-blind, placebo-controlled cl
Publikováno v:
Bulletin of experimental biology and medicine. 135
The efficiency of potentiated preparations from ethanol and morphine hydrochloride in the therapy of patients with alcohol and opium withdrawal syndromes was compared in an open clinical trial. Potentiated ethanol relieved the major clinical manifest
Autor:
A G, Gofman, E N, Krylov, T A, Kozhinova, T I, Nizhnichenko, V V, Khanykov, O S, Sheveleva, O I, Epstein, I V, Yashkina
Publikováno v:
Bulletin of experimental biology and medicine. 135
We studied the efficiency of ANAR containing antibodies to morphine (dilutions C300 and C200) in the therapy of patients with the opium withdrawal syndrome. In patients with moderate to severe forms of the opium withdrawal syndrome therapeutic activi
Publikováno v:
Bulletin of experimental biology and medicine. 135
The efficiency of Proproten-100 containing antibodies to S100 protein in ultralow doses and used to relieve somatovegetative and psychoneurological manifestations of the alcohol withdrawal syndrome was studied in a double-blind, placebo-controlled cl
Autor:
I. V. Yashkina, E. N. Krylov, O. S. Sheveleva, A. G. Gofman, V. V. Khanykov, O. I. Epshtein, T. A. Kozhinova, T. I. Nizhnichenko
Publikováno v:
Bulletin of Experimental Biology and Medicine. :181-182
We studied the efficiency of ANAR containing antibodies to morphine (dilutions C300 and C200) in the therapy of patients with the opium withdrawal syndrome. In patients with moderate to severe forms of the opium withdrawal syndrome therapeutic activi